Stability studies ofphenylbutazone and phenylbutazone--antacid oral formulations. 1978

F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering

UI MeSH Term Description Entries
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D000863 Antacids Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. Alkalinizing Agent,Antacid,Alkalinizing Agents,Agent, Alkalinizing,Agents, Alkalinizing
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
January 2014, International journal of pharmaceutics,
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
November 2021, Molecules (Basel, Switzerland),
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
January 2010, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria,
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
March 1985, Canadian Medical Association journal,
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
August 1985, Canadian Medical Association journal,
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
January 2020, Journal of the American Pharmacists Association : JAPhA,
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
December 1994, Journal of clinical pharmacy and therapeutics,
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
January 2012, ISRN pharmaceutics,
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
February 2013, International journal of pharmaceutics,
F Matsui, and D L Roberston, and P Lafontaine, and H Kolasinski, and E G Lovering
September 2014, British dental journal,
Copied contents to your clipboard!